See the DrugPatentWatch profile for bayer
What did Insilico and Bayer work on together?
The provided information doesn’t specify any particular collaboration, drug candidate, or agreement between Insilico Medicine and Bayer. Without more context (for example, the disease area, program name, or deal announcement date), it’s not possible to accurately describe what they worked on.
Which Bayer business unit is involved (pharma, oncology, crop science, etc.)?
Bayer operates across multiple sectors. To determine whether the connection is in Bayer’s pharmaceuticals pipeline or another area, you’d need at least one of the following:
- the specific Bayer brand or program name
- the therapeutic area (oncology, ophthalmology, etc.)
- a press-release link or approximate timeframe
Are you asking about a specific drug or partnership announcement?
If you mean a particular transaction (e.g., research collaboration, AI/biomarker partnership, licensing), send one more detail and I’ll answer directly—such as:
- “Insilico + Bayer for [disease]”
- “the Bayer deal announced in [month/year]”
- “the candidate name”
Quick way to get the right answer
Reply with either:
1) the exact wording you saw (or paste the snippet), or
2) the name of the program/drug, and I’ll identify the collaboration and summarize what’s known.
Sources
No sources cited because no specific Insilico–Bayer program details were provided.